Genito Urinary Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Genito Urinary Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Genito Urinary Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors th…
Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It…
Background: A person s tumor is studied for mutations. When cells are found that can attack the mutation in a person s tumor, the genes from those cells are st…
Background: The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the labo…
Substantial progress has been made in the treatment of cancer through the use of targeted therapies, but what works for one patient might not work for another p…
Background: Genitourinary cancers are some of the most common types of cancer. They are lethal when they spread. The drug M7824 blocks the paths that cancer ce…
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment disconti…
Radical Cystectomy (RC) remains the gold standard for localized muscle-invasive bladder cancer (MIBC); however, use of ureteral stents at time of surgery remain…